NSE ScannerOpen the scanner

Hospitals & Diagnostics · Medical/Nursing Services · NSE: GAUDIUMIVF · data 2026-10-30

Gaudium IVF & Women Health Ltd.

₹105.86-4.69% on 30 OctHealth: Strong 8.3/10
Feb 2026Low ₹70.67 · High ₹158.16+31.9%

In plain words

Price: 35.1% below its 52-week high of ₹163.18.

Delivery: 47.8% of traded shares were kept for delivery over the last 10 sessions, against 47.6% over the last 59.

Latest results: a net profit of ₹2 cr for the quarter ended Jun 2026.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹105.86
Market cap
₹808 cr
P/E
—
P/B
—
ROE
24.7%
ROCE
35.0%
Debt / equity
0.16
Dividend yield
0.00%
1-year return
27.5%
52-week high
₹163.18
52-week low
₹69.18
Operating margin
—

Growth

Revenue (last 12 months)—
Net profit (last 12 months)—
Sales growth, 3 years (yearly)33.1%
Profit growth, 3 years (yearly)21.8%

Latest results in brief (Q1 FY27)

GAUDIUMIVF Q1 FY27 results (consolidated figures, as filed on NSE).

Revenue was ₹19.38 crore, down 36.1% QoQ.

Net profit was ₹1.78 crore, down 78.7% QoQ.

Operating margin was 12.5%.

EPS was ₹0.25, down 81.3% QoQ.

GAUDIUMIVF के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।

राजस्व: ₹19.38 करोड़; पिछली तिमाही की तुलना में 36.1% की गिरावट।

शुद्ध मुनाफ़ा: ₹1.78 करोड़; पिछली तिमाही की तुलना में 78.7% की गिरावट।

ऑपरेटिंग मार्जिन: 12.5%।

EPS: ₹0.25; पिछली तिमाही की तुलना में 81.3% की गिरावट।

GAUDIUMIVFના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹19.38 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 36.1% ઘટાડો.

ચોખ્ખો નફો: ₹1.78 કરોડ; ગયા ક્વાર્ટરની સરખામણીએ 78.7% ઘટાડો.

ઓપરેટિંગ માર્જિન: 12.5%.

EPS: ₹0.25; ગયા ક્વાર્ટરની સરખામણીએ 81.3% ઘટાડો.

Written from the filed numbers. Not a recommendation.

Smart-money activity

5/100 · Weak over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-08-13: Q1 FY27 results: net profit ₹1.8 cr2026-05-29: Q4 FY26 results: net profit ₹8.4 cr2026-03-18: Q3 FY26 results: net profit ₹3.6 cr

● Results

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (consolidated)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Jun 2026₹19 cr₹2 cr—12.5%0.25
Mar 2026₹30 cr₹8 cr—40.1%1.34
Dec 2025₹25 cr₹4 cr—26.7%0.59

Shareholding trend

HolderSept 2026Jun 2026Mar 2026
Promoters71.29%71.29%71.29%
Foreign institutions (FII)1.19%3.02%6.70%
Domestic institutions (DII)2.22%2.22%2.62%
Mutual funds0.00%——
Retail investors11.58%9.81%7.97%
Number of shareholders24,05121,91019,854

Common questions

What was Gaudium IVF & Women Health Ltd.'s latest quarterly profit?

Gaudium IVF & Women Health Ltd. reported a net profit of ₹2 cr for the quarter ended Jun 2026, on revenue of ₹19 cr.

How much do promoters hold in Gaudium IVF & Women Health Ltd.?

Promoters held 71.29% of Gaudium IVF & Women Health Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.

Is Gaudium IVF & Women Health Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.16.

What is the 52-week high and low of Gaudium IVF & Women Health Ltd.?

The 52-week high is ₹163.18 and the 52-week low is ₹69.18.

Similar companies

Laxmi Dental Ltd. (LAXMIDENTL) · Unihealth Hospitals Ltd (UNIHEALTH) · Max India Ltd (MAXIND) · CHANDAN HEALTHCARE LIMITED (CHANDAN) · Rays of Belief Limited (MOMSBELIEF)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open GAUDIUMIVF in NSE Scanner →
Share on WhatsAppShare on Telegram